Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Leukemia, Myeloid, Acute × Antimetabolites × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Liver Neoplasms 1 Leukemia, Myeloid, Acute 1 Gallbladder Neoplasms 1 Esophageal Neoplasms 1 Colonic Neoplasms 1 Breast Neoplasms 1 Biliary Tract Neoplasms 1

Interventions

Cytarabine 505 Azacitidine 344 venetoclax 275 Cyclophosphamide 256 fludarabine 214 fludarabine phosphate 203 Decitabine 168 Busulfan 150 Idarubicin 137 Daunorubicin 136 Filgrastim 122 Peripheral Blood Stem Cell Transplantation 119 Mycophenolic Acid 117 Whole-Body Irradiation 115 Etoposide 106 Tacrolimus 102 Granulocyte Colony-Stimulating Factor 101 Mitoxantrone 95 Melphalan 92 Cyclosporine 90 Methotrexate 88 Gemtuzumab 78 Clofarabine 77 Antilymphocyte Serum 73 Injections 61 Specimen Handling 60 Stem Cell Transplantation 57 CPX-351 53 Biopsy 47 Radiotherapy 45

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01960387 2016-08-02

UPCI 13-066

University of Pittsburgh

Phase 2 Terminated

2 enrolled 6 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡